Home > PB Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of BALAXI PHARMACEUTICALS is 1.53.

Share Price ₹54.9Jun 10,2025
Market Cap ₹303.3 Cr
Book Value₹197.6 CrMar2024 - Consolidated Results
Price/Book 1.53xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of BALAXI PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹303.3 Cr] as on Jun 10,2025

(/) Book Value [ ₹197.6 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 1.53x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay '1.53 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of BALAXI PHARMACEUTICALS


PB Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/b ratio is 1.53x.

- BALAXI PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.94x.

- BALAXI PHARMACEUTICALS 's operated at median p/b ratio of 3.11x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/b ratio peaked in Mar2021 at 8.07x.

- BALAXI PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2020 of 2.67x.


How does BALAXI PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Book ValuePB RatioMarket Cap
BALAXI PHARMACEUTICALS 197.591.53303.3
ADANI ENTERPRISES LTD47,690.006.33301,668.0
REDINGTON LTD8,721.042.6322,894.3
MMTC LTD1,625.686.6810,866.0
HONASA CONSUMER LTD1,179.838.7810,355.5
LLOYDS ENTERPRISES LTD3,020.662.988,992.7
ENTERO HEALTHCARE SOLUTIONS LTD1,724.153.035,232.0
OPTIEMUS INFRACOM LTD426.4812.305,246.5
POLO QUEEN INDUSTRIAL & FINTECH LTD167.3712.332,064.2
MSTC LTD738.415.353,948.7
SG MART LTD1,208.154.315,212.0

Trading Industry Benchmark (Top 10) PB Analysis vs BALAXI PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 1.53x
Max industry PB 12.33x
Median industry PB 5.35x
Average industry PB 6.02x



You may also like the below Video Courses